news
Metastatic melanoma treatment gets Breakthrough Therapy Designation
Breakthrough Therapy Designation has been granted for investigational agent bempegaldesleukin in combination with nivolumab.
List view / Grid view
Drug Markets
news
Pharmaceutical chemical market to witness significant growth
The rise of manufacturing advanced drugs will stimulate growth in the pharmaceutical chemical market.
article
Climate change: how pharma will profit from a warming planet
Rising temperatures will likely accelerate the spread of vector-borne diseases, resulting in an increased demand for vaccines. European Pharmaceutical Review investigates a Morgan Stanley report on the pharmaceutical beneficiaries of climate change.
news
Millions to be invested to prevent drug shortages for no-deal Brexit
A fund of almost £450 million has been announced by the UK Government to mitigate drug shortages in the event of a no-deal Brexit.
news
US Food and Drug Administration approves Recarbrio
A three-drug combination injection to treat patients with complicated urinary tract and intra-abdominal infections has been approved by the FDA.
news
Ontario and Quebec against plan to lower Canadian drug prices
The two Canadian provinces have expressed concern over the new draft regulations, claiming that the reforms would delay patient access to medicines.
news
FTC investigates contracts regarding autoimmune disease drug, Remicade
The US Federal Trade Commission is investigating whether Johnson and Johnson violated antitrust laws with its medication, Remicade.
news
Indian drug makers looking to expand in Chinese pharma industry
According to a new report, pharma companies in India are increasingly entering the Chinese pharma industry through joint ventures.
news
US sanctions on Iran creating critical drug shortage
The Middle Eastern country has a limited supply of vital medication needed for conditions such as cancer due to US trade blocks.
news
Nubeqa® approved by the US Food and Drug Administration
FDA approves Nubeqa (darolutamide) as a new treatment for men with non-metastatic castration-resistant prostate cancer.
news
Pharmaceutical robots market to see significant growth
The global pharmaceutical robots market is set to be worth $344.4m at the end of a forecast period, after seeing substantial growth.
news
Brand-brand competition will not reduce prices of drugs in US
A new study undertaken to better understand the economic impact of brand-brand competition finds this does not lower drug prices.
news
Trump drafts plan to import drugs from Canada
In another bid to lower medication prices in the US, Donald Trump has announced a draft plan to import drugs from Canada.
news
AstraZeneca and Novartis set to lose out from US drug prices reforms
A report has suggested that the drug price reforms in the US will affect AstraZeneca and Novartis negatively, but Novo could benefit.
news
Cannabidiol-based treatment receives marketing approval from EMA
EMA’s human medicines committee had cleared the cannabidiol oral solution, Epidiolex, for use to treat seizures.
